+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopharmaceutical Market (2021-2026) by Product Type, Therapeutic Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 230 Pages
  • May 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5397295
The Global Biopharmaceutical Market is estimated to be USD 330.7 Bn in 2021 and is expected to reach USD 478.08 Bn by 2026, growing at a CAGR of 7.65%.

Market Dynamics

The factors such as constant innovations in biopharmaceutics, the growing elderly population, increasing unhealthy lifestyle, rising chronic diseases, and focus on research and related investments have prompted the demand of the global biopharmaceutical market. According to the Globocan 2020 report, 19,292,789 new cancer cases were diagnosed, with 9,958,133 deaths due to cancers worldwide. Growing healthcare expenditures, improved healthcare infrastructures, and government initiatives in the biopharmaceutical sector are anticipated to increase market growth further. However, some factors, such as stringent pharmaceutical regulations, can create hindrances in innovating new novel drugs that may affect the market growth.
Rising adoption in emerging economies is expected to generate untapped opportunities for market participants.

Market Segmentation

The Global Biopharmaceutical Market is segmented further based on Product Type, Therapeutic Application, and Geography.

By Product Type, the market is classified into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, recombinant enzymes, cell and gene therapies, and others. Amongst all, the monoclonal antibodies segment is estimated to hold the highest market share during the forecast period.

By Therapeutic Application, the market is classified as oncology, cardiology, neurology, autoimmune disorders, hormonal disorders, and others. Amongst all, the oncology segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Pfizer acquired Amplyx pharmaceuticals to advance the anti-infectives pipeline - 30th April 2021.
2. Biogen and Bio-Thera Solutions announce commercialization and license agreement for bat1806 - 13th April 2021.

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Amgen Inc, Beijing SL Pharmaceutical Co Ltd, Biocon Ltd, Biological E. Limited, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Biopharmaceutical Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Biopharmaceutical Market

What is the estimated value of the Global Biopharmaceutical Market?

The Global Biopharmaceutical Market was estimated to be valued at $330700 Million in 2021.

What is the growth rate of the Global Biopharmaceutical Market?

The growth rate of the Global Biopharmaceutical Market is 7.6%, with an estimated value of $478080 Million by 2026.

What is the forecasted size of the Global Biopharmaceutical Market?

The Global Biopharmaceutical Market is estimated to be worth $478080 Million by 2026.

Who are the key companies in the Global Biopharmaceutical Market?

Key companies in the Global Biopharmaceutical Market include Abbott Laboratories, Amgen Inc, Beijing SL Pharmaceutical Co Ltd, Biocon Ltd, Biological E Limited, Cadila Healthcare Limited (Zydus Cadila), Celltrion, Inc, Eli Lilly and Company and La Roche Ltd..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increases in Prevalence of Chronic Diseases
4.1.2 Surges in Demand for Biopharmaceutical Medicines
4.2 Restraints
4.2.1 Stringent Government Regulations
4.2.2 High-end Manufacturing Requirements
4.3 Opportunities
4.3.1 Increasing Investments in Research and Development
4.3.2 Rising Adoption in Emerging Economies
4.4 Challenges
4.4.1 Lack of Skilled Personnel
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Biopharmaceutical Market, By Product Type
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Anti-cancer Monoclonal Antibodies
6.2.2 Anti-inflammatory Monoclonal Antibodies
6.2.3 Other Monoclonal Antibodies
6.3 Recombinant Growth Factors
6.3.1 Erythropoietin
6.3.2 Granulocyte Colony Stimulating Factor
6.4 Purified Proteins
6.4.1 Leukemia Inhibitory Factor (LIF)
6.4.2 P53 Protein
6.4.3 P38 Protein
6.4.4 Other Purified Proteins
6.5 Recombinant Proteins
6.5.1 Serum Albumin
6.5.2 Amyloid Protein
6.5.3 Defensin
6.5.4 Transferrin
6.6 Recombinant Hormone
6.6.1 Recombinant Human Growth Hormones
6.6.2 Recombinant Insulin
6.6.3 Other Recombinant Hormones
6.7 Vaccines
6.7.1 Recombinant Vaccines Cancer Vaccines Malaria Vaccines Ebola Vaccine Hepatitis B Vaccine Tetanus Vaccine Diptheria Vaccine Cholera Vaccine Other Recombinant Vaccines
6.7.2 Conventional Vaccines Polio Vaccine Pox Vaccine Other Conventional Vaccines
6.8 Synthetic Immunomodulators
6.8.1 Cytokines
6.8.2 Interferons
6.8.3 Interleukins
6.9 Recombinant Enzymes
6.9.1 Enterokinase
6.9.2 Cyclase
6.9.3 Caspase
6.9.4 Cathepsin
6.10 Cell and Gene Therapies
6.10.1 Allogenic Products
6.10.2 Autologous Products
6.10.3 Acellular Products
6.11 Others
6.11.1 Blood Factors
6.11.2 Other Product Types
7 Global Biopharmaceutical Market, By Therapeutic Application
7.1 Introduction
7.2 Oncology
7.3 Cardiology
7.4 Neurology
7.5 Autoimmune Disorders
7.6 Hormonal Disorders
7.7 Others
8 Global Biopharmaceutical Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Abbott Laboratories
10.2 Amgen Inc
10.3 Beijing SL Pharmaceutical Co Ltd
10.4 Biocon Ltd
10.5 Biological E Limited
10.6 Cadila Healthcare Limited (Zydus Cadila)
10.7 Celltrion, Inc
10.8 Eli Lilly and Company
10.9 F. Hoffmann-La Roche Ltd.
10.10 Glenmark Pharmaceuticals Limited
10.11 GVK Biosciences Pvt Ltd
10.12 Hualan Biological Engineering Inc
10.13 Johnson & Johnson
10.14 Merck & Co., Inc
10.15 Novo Nordisk A/S
10.16 Pfizer Inc.
10.17 Reliance Life Sciences Pvt Ltd
10.18 RPG Life Sciences Limited
10.19 Samsung Biologics Co Ltd
10.20 Sanofi S.A.
10.21 Shanghai Institute of Biological Products
10.22 Shantha Biotechnics Ltd
10.23 Sun Pharmaceutical Industries Ltd
10.24 Suven Life Sciences Ltd
10.25 Takeda Pharmaceutical Company Limited
10.26 Torrent Pharmaceuticals Limited
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Amgen Inc
  • Beijing SL Pharmaceutical Co Ltd
  • Biocon Ltd
  • Biological E Limited
  • Cadila Healthcare Limited (Zydus Cadila)
  • Celltrion, Inc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Limited
  • GVK Biosciences Pvt Ltd
  • Hualan Biological Engineering Inc
  • Johnson & Johnson
  • Merck & Co., Inc
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Reliance Life Sciences Pvt Ltd
  • RPG Life Sciences Limited
  • Samsung Biologics Co Ltd
  • Sanofi S.A.
  • Shanghai Institute of Biological Products
  • Shantha Biotechnics Ltd
  • Sun Pharmaceutical Industries Ltd
  • Suven Life Sciences Ltd
  • Takeda Pharmaceutical Company Limited
  • Torrent Pharmaceuticals Limited